Altimmune (ALT) Return on Sales Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,231.00 |
| Sep 30, 2025 | -3,797.00 |
| Jun 30, 2025 | -4,426.00 |
| Mar 31, 2025 | -3,913.00 |
| Dec 31, 2024 | -4,629.00 |
| Sep 30, 2024 | -4,552.00 |
| Jun 30, 2024 | -4,926.00 |
| Mar 31, 2024 | -4,878.00 |
| Dec 31, 2023 | -229.00 |
| Sep 30, 2023 | -56.00 |
| Jun 30, 2023 | -2,692.00 |
| Mar 31, 2023 | -956.00 |
| Dec 31, 2022 | 1,970.00 |
| Sep 30, 2022 | -11,751.00 |
| Jun 30, 2022 | -2,515.00 |
| Mar 31, 2022 | -599.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 762.00 |
| Jun 30, 2021 | -178.00 |
| Mar 31, 2021 | -17.00 |
| Dec 31, 2020 | -4.00 |
| Sep 30, 2020 | -5.00 |
| Jun 30, 2020 | -2.00 |
| Mar 31, 2020 | -2.00 |
| Dec 31, 2019 | -6.00 |
| Sep 30, 2019 | -12.00 |
| Jun 30, 2019 | -2.00 |
| Mar 31, 2019 | 0.00 |
| Dec 31, 2018 | -11.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | -3.00 |
| Mar 31, 2018 | -1.00 |
| Dec 31, 2017 | -5.00 |
| Sep 30, 2017 | -6.00 |
| Jun 30, 2017 | -1.00 |
| Mar 31, 2017 | -12.00 |
| Dec 31, 2016 | -3.00 |
| Sep 30, 2016 | -974.00 |
| Jun 30, 2016 | -2.00 |
| Mar 31, 2016 | -1.00 |
| Dec 31, 2015 | 1.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | -1.00 |